Clinical trial
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients…
NCT00004063 · The University of Texas Health Science Center, Houston, Other · Unknown status
Key facts
| NCT number | NCT00004063 |
|---|---|
| Title | Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer |
| Official title | A Phase I-II Clinical Trial of Cisplatin (Platinol) Followed by Gemcitabine HCl (Gemzar) in Combination With Mild, Fever-Range Whole Body Hyperthermia (LL-WBH) at 40C in Patients With Advanced Malignancies |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug, Procedure |
| Interventions | recombinant interferon alfa, cisplatin, gemcitabine hydrochloride, hyperthermia treatment |
| Enrollment | 30 |
| Start date | Aug 1, 1999 |
| Primary completion | Nov 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 30, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: